DB19161InvestigationalSmall molecule
Pudexacianinium is under investigation in clinical trial NCT05754333 (A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery).
- Formula / weight
- C135H197N4O73 · 3044.015 g/mol (avg)
- Also known as
- .beta.-cyclodextrin, 2a-o-(3-aminopropyl)-, diamide with 3-(2-carboxyethyl)-2-(2-(3-(2-(3-(2-carboxyethyl)-1,3-dihydro-1,1-dimethyl-2h-benz(e)indol-2-ylidiene)ethylidene)-2-methoxy-1-cyclohexen-1-yl)ethylene)-1,1-dimethyl-1h-benz(e)indolium ion · 3-(3-((3-(CYCLOMALTOHEPTAOS-21-O-YL)PROPYL)AMINO)-3-OXOPROPYL)-2-((1E)-2-((3E)-3-((2E)-2-(3-(3-((3-(CYCLOMALTOHEPTAOS-21-O-YL)PROPYL)AMINO)-3-OXOPROPYL)-1,1-DIMETHYL-1,3-DIHYDRO-2H-BENZO(E)INDOL-2-YLIDENE)ETHYLIDENE)-2-METHOXYCYCLOHEX-1-EN-1-YL)ETHEN-1-Y · Pudexacianinium ion
- Code names
- ASP-5354
Resolves to
Compound
Structure
InChIKey
YTSRTYDSGUUGAS-ZKNIEEHQSA-OSMILES[H][C@@]12O[C@H](CO)[C@@]([H])(O[C@@]3([H])O[C@H](CO)[C@@]([H])(O[C@@]4([H])O[C@H](CO)[C@@]([H])(O[C@@]5([H])O[C@H](CO)[C@@]([H])(O[C@@]6([H])O[C@H](CO)[C@@]([H])(O[C@@]7([H])O[C@H](CO)[C@@]([H])(O[C@@]8([H])O[C@H](CO)[C@@]([H])(O1)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](OCCCNC(=O)CC[N+]1=C(\C=C\C6=C(OC)C(CCC6)=C\C=C6\N(CCC(=O)NCCCO[C@@H]7[C@@H](O)[C@]8([H])O[C@@]9([H])O[C@H](CO)[C@@]([H])(O[C@@]%10([H])O[C@H](CO)[C@@]([H])(O[C@@]%11([H])O[C@H](CO)[C@@]([H])(O[C@@]%12([H])O[C@H](CO)[C@@]([H])(O[C@@]%13([H])O[C@H](CO)[C@@]([H])(O[C@@]%14([H])O[C@H](CO)[C@@]([H])(O[C@@]7([H])O[C@@H]8CO)[C@H](O)[C@H]%14O)[C@H](O)[C@H]%13O)[C@H](O)[C@H]%12O)[C@H](O)[C@H]%11O)[C@H](O)[C@H]%10O)[C@H](O)[C@H]9O)C7=C(C8=CC=CC=C8C=C7)C6(C)C)C(C)(C)C6=C1C=CC1=CC=CC=C61)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2OWhat you can answer from here — as of April 23, 2025
Which companies are running trials of Pudexacianinium, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account